There is now considerable evidence demonstrating that the recruitment of leukocytes from the circulation to sites of tissue injury or inflammation is mediated by a sequential cascade of leukocyte–endothelial cell interactions (1). Tethering and rolling are the first interactions that occur between circulating leukocytes and endothelial cells. Rolling leukocytes can be activated to firmly adhere to the vascular endothelium, and subsequently emigrate between endothelial cells into the extravascular space. Each of these events is known to be mediated by distinct classes of adhesion molecules; selectins are responsible for leukocyte tethering and rolling, while β2 integrins and members of the immunoglobulin superfamily mediate adhesion and emigration. In contrast, very little is known about existing antiadhesive mechanisms that may regulate or attenuate the inflammatory response. A functional barrier that prevents leukocyte– endothelial cell interactions through either steric hindrance or charge repulsion may be one potential mechanism.
One such barrier may be provided by the cell-surface sialoglycoprotein CD43 (leukosialin), a molecule expressed exclusively on hematopoietically derived cells (2, 3). There are several compelling reasons to consider that CD43 may have an important role in cell–cell interactions. First, its structure is consistent with a barrier inasmuch as the extracellular domain of CD43 is extraordinarily long and extends 45 nm from the plasma membrane (4). Through steric hindrance, CD43 may interfere with the ability of other adhesion molecules, including L-selectin (5), to interact with their ligands. Second, CD43 has abundant sialic acid residues that impart a net negative surface charge thought to retard cell–cell interactions (6). Desialation of neutrophils has been associated with a reduction in cell-surface charge and increased adhesiveness, homotypic aggregation, and cell-spreading (6, 7). Third, CD43 is partially downregulated by proteolytic shedding after cellular activation (6, 8) perhaps exposing adhesion molecules and reducing repulsive forces.
Studies using an antibody directed against CD43 do not support the view that CD43 is antiadhesive—in fact this antibody appears to reduce the recruitment of leukocytes into tissues (9, 10). Although it is conceivable that anti-CD43 antibodies could paradoxically enhance barrier function by increasing steric hindrance, it is also possible that CD43 functions as a homing receptor promoting leukocyte recruitment into tissues or as an accessory molecule enhancing leukocyte rolling, adhesion, and emigration. Using the CD43-deficient (CD43–/–) mouse described by Manjunath et al. (11) and intravital microscopy to visualize leukocyte kinetics in vivo (12), we directly visualized and investigated the function of CD43 in leukocyte–endothelial cell interactions within the cremasteric microcirculation under flow conditions. Our results demonstrate that leukocyte rolling and adhesion induced by chemotactic stimuli are enhanced in CD43–/– mice compared with wild-type control animals, but unexpectedly there is an inability of CD43–/– leukocytes (namely neutrophils and monocytes) to emigrate out of the vasculature.
 |
Materials and Methods
|
|---|
Animals.
CD43-deficient mice (CD43–/–) produced by homologous recombination in embryonic stem cells were generated in a mixed background of 129/SvEv x C57BL/6 as previously described (11), and were obtained from The Jackson Laboratory (Bar Harbor, ME). Wild-type mice derived from the same background were used as controls. Animals were bred and housed in specific pathogen-free facilities and used between 6 and 12 wk of age.
Mouse Cremaster Preparation.
The mouse cremaster preparation was used to investigate leukocyte–endothelial cell interactions in the microcirculation (12). Mice were anesthetized by intraperitoneal injection of a mixture of xylazine hydrochloride (10 mg/kg; MTC Pharmaceuticals, Cambridge, Ontario, Canada) and ketamine hydrochloride (200 mg/kg; Rogar/STB Inc., London, Ontario, Canada). The jugular vein was cannulated and used to maintain anesthesia. The cremaster muscle was dissected free of tissues and exteriorized onto an optically clear viewing pedestal. The muscle was cut longitudinally with a cautery and held flat against the pedestal by attaching silk sutures to the corners of the tissue. The muscle was then superfused with bicarbonate-buffered saline warmed to 37°C.
An intravital microscope (Axioskop, Carl Zeiss Inc. Canada, Don Mills, Ontario, Canada) has been described elsewhere. Single unbranched cremasteric postcapillary venules (25–40 µm in diameter) were selected for examination of leukocyte rolling and adhesion. Leukocytes were considered adherent to the venular endothelium if they remained stationary for a period
30 s. Rolling leukocytes were defined as those moving at a velocity less than that of erythrocytes within a given vessel. Leukocyte rolling velocity was calculated from the time taken for a leukocyte to roll 100 µm. Venular diameter (Dv) was measured on-line using a video caliper (Microcirculation Research Institute, Texas A&M University, College Station, TX). Centerline red blood cell velocity (VRBC) was also measured on-line using an optical Doppler velocimeter (Microcirculation Research Institute) and mean red blood cell velocity (Vmean) was determined as VRBC/1.6. Venular wall shear rate was calculated based on the Newtonian definition:
= 8 (Vmean/Dv) (13).
Experimental Protocol.
To determine whether CD43 was capable of regulating leukocyte recruitment induced by an acute chemotactic stimulus, the response to the bacterial peptide N-formyl-methionyl-leucyl-phenylalanine (fMLP; Sigma Chemical Co., St. Louis, MO) was examined. fMLP (10 µM) was superfused over the cremasteric preparations for 60 min and leukocyte rolling and adhesion in postcapillary venules determined at 15-min intervals.
Leukocyte Emigration.
To examine whether leukocyte emigration was impaired in CD43–/– mice, emigration induced by platelet-activating factor (PAF), a potent promoter of leukocyte emigration in the mouse cremaster microcirculation, was studied (14). In this final group of intravital microscopy experiments, cremasteric preparations were superfused for 60 min with 100 nM PAF in a saline solution containing 0.5% BSA. PAF was used because fMLP did not induce emigration in the murine system.
Peritoneal Elicitation.
Mice were given a 1-ml i.p. injection of 1% oyster type II glycogen in sterile saline as previously described (15). After 4 or 24 h, cells were harvested from the peritoneal cavity by lavage via 3 ml of sterile saline, and then counted using a hemocytometer. Differential counting was performed with Wright-Giemsa staining. Finally, to ensure that incomplete harvest was not responsible for lower leukocyte yields in the peritoneum of CD43–/– mice, peritoneums were also lavaged with heparin and EDTA. Similar results were obtained with heparin or EDTA.
Flow Chamber Assay.
To study murine leukocyte behavior under shear conditions in vitro, whole blood was perfused over immobilized E-selectin (5 µg/ml), using a previously described flow chamber assay (12). Coverslips were mounted into a polycarbonate chamber with parallel plate geometry (16) and observed at a magnification of 100 using an inverted microscope equipped with phase-contrast optics (Carl Zeiss Inc. Canada). The stage area was enclosed in a warm air cabinet and maintained at 37°C.
In brief, the blood was diluted 1:10 in HBSS, maintained at 37°C using a water bath, and perfused through the flow chamber at defined wall shear stresses using a syringe pump (Harvard Apparatus Inc., South Natick, MA). All of the experiments described were performed between 2 and 4 dynes/cm2. The blood was perfused over the substrate for 3 min and then chased with HBSS to flush out any remaining erythrocytes and noninteracting leukocytes. At this stage leukocytes interacting with the coverslip could be seen readily and were counted in at least four random fields per coverslip and expressed as the number of interacting cells per field of view.
Statistical Analysis.
All data are presented as mean ± SEM. The data within groups were compared using a paired Student's t test using Bonferroni corrections for multiple comparisons as required. Unpaired t tests were used to compare between groups. Statistical significance was set at P < 0.05.
 |
Results and Discussion
|
|---|
Leukocyte Interactions in Single Microvessels of CD43–/– Mice.
In vivo fMLP (10 µM) superfusion over the cremasteric microcirculation revealed a significant difference in leukocyte kinetics between wild-type (CD43+/+) and CD43–/– mice (Fig. 1). Over the first 60 min of fMLP superfusion, the number of rolling cells in CD43–/– animals was maintained at a constant level and was significantly greater in comparison with wild-type mice (P < 0.05). Moreover, this higher level of rolling was associated with a significant augmentation in leukocyte adhesion (31.3 ± 2.8 in CD43–/– vs. 13.3 ± 2.0 in CD43+/+; n = 7 in each group; P < 0.05). CD43 deficiency did not influence leukocyte rolling velocity.
1 Butcher EC & Picker LJ. Lymphocyte homing and homeostasis, Science, 1996, 272, 60–66.[Abstract]
2 Remold-O'Donnell E, Kenney D & Rosen FS. Expression on blood cells of sialophorin, the surface glycoprotein that is defective in Wiskott-Aldrich Syndrome, Blood, 1987, 70, 104–109.[Abstract/Free Full Text]
3 Remold-O'Donnell E, Kenney D & Rosen FS. Biosynthesis of human sialophorins and analysis of the polypeptide core, Biochemistry, 1987, 26, 3908–3913.[Medline]
4 Cyster JG, Shotton DM & Williams AF. The dimensions of the T lymphocytes glycoprotein leukosialin and identification of linear protein epitopes that can be modified by glycosylation, EMBO (Eur Mol Biol Organ) J, 1991, 10, 893–902.[Medline]
5 Stockton BM, Cheng G, Manjunath N, Ardman B & von Andrian U. Negative regulation of T cell homing by CD43, Immunity, 1998, 8, 373–381.[Medline]
6 Nathan C, Xie QW, Halbwachs-Mercarelli L & Jin WW. Albumin inhibits neutrophil spreading and hydrogen peroxide release by blocking the shedding of CD43 (sialophorin, leukosialin), J Cell Biol, 1993, 122, 243–256.[Abstract/Free Full Text]
7 Gallin JI, Durocher JR & Kaplan AP. Interaction of leukocyte chemotactic factors with the cell surface. I. Chemotactic factor-induced changes in human granulocyte surface charge, J Clin Invest, 1975, 55, 967–974.[Medline]
8 Remold-O'Donnell E & Parent D. Two proteolytic pathways for downregulation of the barrier molecule CD43 of human neutrophils, J Immunol, 1994, 152, 3595–3605.[Abstract]
9 McEvoy LM, Sun H, Frelinger JG & Butcher EC. Anti-CD43 inhibition of T cell homing, J Exp Med, 1997, 185, 1493–1498.[Abstract/Free Full Text]
10 McEvoy LM, Jutila MA, Tsao PS, Cooke JP & Butcher EC. Anti-CD43 inhibits monocyte–endothelial adhesion in inflammation and atherogenesis, Blood, 1997, 90, 3587–3594.[Abstract/Free Full Text]
11 Manjunath N, Correa M, Ardman M & Ardman B. Negative regulation of T-cell adhesion and activation by CD43, Nature, 1995, 377, 535–538.[Medline]
12 Hickey MJ, Sharkey KA, Sihota EG, Reinhardt PH, Macmicking JD, Nathan C & Kubes P. Inducible nitric oxide synthase–deficient mice have enhanced leukocyte–endothelium interactions in endotoxemia, FASEB (Fed Am Soc Exp Biol) J, 1997, 11, 955–964.[Abstract]
13 House SD & Lipowsky HH. Leukocyte–endothelium adhesion: microhemodynamics in mesentery of the cat, Microvasc Res, 1987, 34, 363–379.[Medline]
14 Woodman RC, Reinhardt PH, Kanwar S, Johnston FL & Kubes P. Effects of human neutrophil elastase (HNE) on neutrophil function in vitro and in inflamed microvessels, Blood, 1993, 82, 2188–2195.[Abstract/Free Full Text]
15 Bhopale KK, Masani KB, Pradhan KS & Kaul CL. A simple quantitative in vitromacrophage migration assay, Indian J Exp Biol, 1996, 34, 968–977.[Medline]
16 Lawrence MB, Smith CW, Eskin SG & McIntire LV. Effect of venous shear stress on CD18-mediated neutrophil adhesion to cultured endothelium, Blood, 1990, 75, 227–237.[Abstract/Free Full Text]
17 Springer TA, Thompson WS, Miller LJ, Schmalstieg FC & Anderson DC. Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis, J Exp Med, 1984, 160, 1901–1918.[Abstract/Free Full Text]
18 Wong J, Johnston B, Lee SS, Bullard DC, Smith CW, Beaudet AL & Kubes P. A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature, J Clin Invest, 1997, 99, 2782–2790.[Medline]
19 Ardman B, Sikorski MS & Staunton DE. CD43 interferes with T lymphocyte adhesion, Proc Natl Acad Sci USA, 1992, 89, 5001–5005.[Abstract/Free Full Text]
20 Rosenstein Y, Park JK, Hahn WC, Rosen FS, Bierer BE & Burakoff SJ. CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1, Nature, 1991, 354, 233–235.[Medline]
21 Marlin SD & Springer TA. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function–associated antigen 1 (LFA-1), Cell, 1987, 51, 813–819.[Medline]
22 Kuijpers TW, Hoogerwerf M, Kuijpers KC, Schwartz BR & Harlan JM. Cross-linking of sialophorin (CD43) induces neutrophil aggregation in a CD18-dependent and a CD18-independent way, J Immunol, 1992, 149, 998–1003.[Abstract]
23 Picker LJ, Warnock RA, Burns AR, Doerschuk CM, Berg EL & Butcher EC. The neutrophil selectin LECAM-1 presents carbohydrate ligands to the vascular selectins ELAM-1 and GMP-140, Cell, 1991, 66, 921–933.[Medline]
24 Berlin C, Bargatze RF, Campbell JJ, von Andrian UH, Szabo MC, Hassien SR, Nelson RD, Berg EL, Erlandsen SL & Butcher EC.
4 integrins mediate lymphocyte attachment and rolling under physiologic flow, Cell, 1995, 80, 413–422.[Medline]
25 Moore KL, Patel KD, Bruehl RE, Fugang L, Johnson DA, Lichenstein HS, Cummings RD, Bainton DF & McEver RP. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin, J Cell Biol, 1995, 128, 661–671.[Abstract/Free Full Text]
26 Axelsson B, Yoouseffi-Etemad R, Hammarström S & Perlmann P. Induction of aggregation and enhancement of proliferation and IL-2 secretion in human T cells by antibodies to CD43, J Immunol, 1988, 141, 2912–2917.[Abstract]
27 Nong NH, Remold-O'Donnell E, LeBien TW & Remold HG. A monoclonal antibody to sialophorin (CD43) induces homotypic adhesion and activation of human monocytes, J Exp Med, 1989, 170, 259–267.[Abstract/Free Full Text]
28 Manjunath N, Johnson RS, Staunton DE, Pasqualini R & Ardman B. Targeted disruption of CD43 gene enhances T lymphocyte adhesion, J Immunol, 1993, 151, 1528–1534.[Abstract]
29 De Smet W, Walter H & Van Hove L. A new CD43 monoclonal antibody induces homotypic aggregation of human leukocytes through a CD11a/CD18 dependent and independent mechanism, Immunology, 1993, 79, 46–54.[Medline]
30 Sanchez-Mateos P, Campanero MR, del Pozo MA & Sanchez-Madrid F. Regulatory role of CD43 leukosialin on integrin-mediated T-cell adhesion to endothelial and extracellular matrix ligands and its polar redistribution to a cellular uropod, Blood, 1995, 86, 2228–2239.[Abstract/Free Full Text]
31 Hernandez-Caselles T, Martinez-Esparza M, Lazarovits AI & Aparicio P. Specific regulation of VLA-4 and alpha 4 beta 7 integrin expression on human activated T lymphocytes, J Immunol, 1996, 156, 3668–3677.[Abstract]
32 Howell DN, Ahuja V, Jones L, Blow O & Sanfilippo FP. Differential expression of CD43 (leukosialin, sialophorin) by mononuclear phagocyte populations, J Leukoc Biol, 1994, 55, 536–544.[Abstract]
33 Lopez S, Halbwachs-Mercarelli L, Ravaud P, Bessou G, Dougados M & Porteu F. Neutrophil expression of tumour necrosis factor receptors (TNF-R) and of activation markers (CD11b, CD43, CD63) in rheumatoid arthritis, Clin Exp Immunol, 1995, 101, 25–32.[Medline]
34 Woodman RC, Johnston FL, Teoh D & Maric M. Shedding of neutrophil CD43 (leukosialin) requires a protease(s) localized to secondary granules, Blood, 1997, 90, 14a.